2740
KERALISE FACE CREAM FOR ACNE AND IMPURE SKIN GLYCOLIC ACID 6% 30 ML
KERALISE FACE CREAM FOR ACNE AND IMPURE SKIN GLYCOLIC ACID 6% 30 ML
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
KERALISE
COMEDOLITIC CREAM
Comedolytic exfoliating and purifying cream. Concentrated soothing and purifying formula. Nickel tested. Dermatologically tested. Preservative-free.
Hypoallergenic perfume.
How to use
Apply to impure areas with a light massage.
Use once or twice daily until improvement occurs. It is recommended to continue using the product periodically.
Components
Pure glycolic acid, salicylic acid, retinol, piroctone olamine, zinc PCA, panthenol, vitamin E, glycyrrhetinic acid.
Conservation
Store at room temperature.
Shelf life when packaging is intact: 36 months.
Shelf life after opening: 12 months.
Format
30 ml tube.
Code 074
2740
KERALISE FACE CREAM FOR ACNE AND IMPURE SKIN GLYCOLIC ACID 6% 30 ML
KERALISE FACE CREAM FOR ACNE AND IMPURE SKIN GLYCOLIC ACID 6% 30 ML
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
